3β,5α-ergostan-3-ol;
General Information
| Mainterm | 3β,5α-ergostan-3-ol; |
| CAS Reg.No.(or other ID) | 474-60-2 |
| Regnum |
From www.fda.gov
Computed Descriptors
Download SDF| 2D Structure | |
| CID | 119394 |
| IUPAC Name | (3S,5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol |
| InChI | InChI=1S/C28H50O/c1-18(2)19(3)7-8-20(4)24-11-12-25-23-10-9-21-17-22(29)13-15-27(21,5)26(23)14-16-28(24,25)6/h18-26,29H,7-17H2,1-6H3/t19-,20-,21+,22+,23+,24-,25+,26+,27+,28-/m1/s1 |
| InChI Key | ARYTXMNEANMLMU-ATEDBJNTSA-N |
| Canonical SMILES | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C |
| Molecular Formula | C28H50O |
| Wikipedia | campestanol |
From Pubchem
Computed Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 402.707 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 5 |
| Complexity | 569.0 |
| CACTVS Substructure Key Fingerprint | A A A D c f B 4 I A A A A A A A A A A A A A A A A A A A A Y A A A A A w Y M A A A A A A A G D A A A A A G g A A C A A A D x S g g A I C A A A A A g A A A A A A A A A A A A A A A A A A A A A A A A A A E A I A A A A A Q A A E A A A A A A G A w P A P g A A A A A A A A A D A A A Y A A C A A A Q A A C A A A A A = = |
| Topological Polar Surface Area | 20.2 |
| Monoisotopic Mass | 402.386 |
| Exact Mass | 402.386 |
| XLogP3 | None |
| XLogP3-AA | 9.6 |
| Compound Is Canonicalized | True |
| Formal Charge | 0 |
| Heavy Atom Count | 29 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
From Pubchem
Food Additives Biosynthesis/Degradation
ADMET Predicted Profile --- Classification
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.9876 |
| Human Intestinal Absorption | HIA+ | 0.9972 |
| Caco-2 Permeability | Caco2+ | 0.8215 |
| P-glycoprotein Substrate | Substrate | 0.6029 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5251 |
| Inhibitor | 0.5425 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7926 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.4739 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.7510 |
| CYP450 2D6 Substrate | Non-substrate | 0.8756 |
| CYP450 3A4 Substrate | Substrate | 0.7423 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7578 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7690 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9708 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8526 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9020 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8376 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8855 |
| Non-inhibitor | 0.6000 | |
| AMES Toxicity | Non AMES toxic | 0.8368 |
| Carcinogens | Non-carcinogens | 0.8914 |
| Fish Toxicity | High FHMT | 0.9872 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9897 |
| Honey Bee Toxicity | High HBT | 0.8091 |
| Biodegradation | Not ready biodegradable | 0.9959 |
| Acute Oral Toxicity | III | 0.8331 |
| Carcinogenicity (Three-class) | Non-required | 0.6887 |
From admetSAR
ADMET Predicted Profile --- Regression
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -4.5478 | LogS |
| Caco-2 Permeability | 1.4377 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 2.3821 | LD50, mol/kg |
| Fish Toxicity | 0.5342 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 1.4253 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
| Kingdom | Organic compounds |
|---|---|
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| Subclass | Ergostane steroids |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Ergosterols and derivatives |
| Alternative Parents | |
| Molecular Framework | Aliphatic homopolycyclic compounds |
| Substituents | Ergosterol-skeleton - 3-beta-hydroxysteroid - Hydroxysteroid - 3-hydroxysteroid - Cyclic alcohol - Secondary alcohol - Organic oxygen compound - Hydrocarbon derivative - Organooxygen compound - Alcohol - Aliphatic homopolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as ergosterols and derivatives. These are steroids containing ergosta-5,7,22-trien-3beta-ol or a derivative thereof, which is based on the 3beta-hydroxylated ergostane skeleton. |
From ClassyFire